In a study conducted on healthy first-degree relatives of Ashkenazi Jewish LRRK2-G2019S-PD patients (120 G2019S carriers, 111 G2019S non-carriers), over 5 years, 4.3% of the individuals were diagnosed with PD, and all were G2019S carriers. Here, LRRK2 is linked to Parkinson disease.